Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Di...

by Gough, Stephen C.L., Bhargava, Anuj, Jain, Rajeev, Mersebach, Henriette, Rasmussen, Søren, Bergenstal, Richard M.
Published 2013

Elderly Patients with Diabetes Experience a Lower Rate of Nocturnal Hypoglycaemia with Insulin Degludec than with Insulin Glargine: A Meta-Analysis of Phase IIIa Trials

by Sorli, Christopher, Warren, Mark, Oyer, David, Mersebach, Henriette, Johansen, Thue, Gough, Stephen C. L.
Published 2013

Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlle...

by Kumar, Ajay, Franek, Edward, Wise, Jonathan, Niemeyer, Marcus, Mersebach, Henriette, Simó, Rafael
Published 2016

Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes: A 26...

by Hirsch, Irl B., Bode, Bruce, Courreges, Jean-Pierre, Dykiel, Patrik, Franek, Edward, Hermansen, Kjeld, King, Allen, Mersebach, Henriette, Davies, Melanie
Published 2012

Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA1c and spikes of high glucose values in the third trimester

by Damm, Peter, Mersebach, Henriette, Råstam, Jacob, Kaaja, Risto, Hod, Moshe, McCance, David R., Mathiesen, Elisabeth R.
Published 2014